PNPLA3 and metabolic dysfunction-associated steatotic liver disease: For instance, the aforementioned PNPLA3 was consistently identified as a NAFLD pathogenesis modifier, independently of whether biochemical indices or radiologically determined TAG accumulation were used in the assessment [47,48,49].